A UK study presented at a conference last weekend found no evidence to support the idea that a daily dose of aspirin protects people who do not have artery or heart disease from developing it in the future any better than a placebo, and experts suggest given the higher risk of internal bleeding from taking aspirin routinely, for healthy people such a precaution may do more harm than good.
The study reported results from the Aspirin for Asymptomatic Atherosclerosis (AAA) study, whose joint first author Professor Gerry Fowkes from the Wolfson Unit for Prevention of Peripheral Vascular Diseases in Edinburgh, presented the findings at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain on Sunday.
Fowkes said the study was the first placebo-controlled randomised trial to test the protective effect of aspirin in people who did not show signs of atherosclerosis as measured by a low ankle brachial index (ABI) at the start of the study, and that the results found:
"No statistically significant difference in primary endpoint events between those subjects allocated to aspirin or placebo."
Comment: If we read the article more closely, we will see that 200 mg of DHA a day is just enough to affect biochemical markers. That dose is by no means enough for optimal health as is implied elsewhere in the article. In fact, research has shown that we need a lot more Omega-3 fatty acids to balance the large amount of Omega-6 fatty acids that we consume everyday.
And as if the above is not misleading enough, the author felt compelled to add the last sentence, insinuating that people should eat fish, which are more likely than not contaminated with mercury than getting Omega-3 supplements. Why is that? Is it because getting Omega-3 supplements is a good and inexpensive way to improve your health and it is not in the interest of big pharma companies?